Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial - Nguyen, Q D; Merrill, P T; Jaffe, G J (Lancet, 2016)